The surveillance error grid

Journal of Diabetes Science and Technology

Volumn 8, Issue 4, 2014, Pages 658-672

  Klonoff, David C ^a   Lias, Courtney ^b   Vigersky, Robert ^c   Clarke, William ^d   Parkes, Joan Lee ^e   Sacks, David B ^f   Kirkman, M Sue ^g   Kovatchev, Boris ^d  

^a Mills Peninsula Health Services   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^c WALTER REED ARMY MEDICAL CENTER   (United States)

^d UNIVERSITY OF VIRGINIA   (United States)

^e Joan Lee Parkes Consulting Inc   (United States)

^f NATIONAL INSTITUTES OF HEALTH   (United States)

^g UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Accuracy; Blood glucose; Error grid; Monitor; Surveillance

Indexed keywords

ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL;

ADULT; AGE; ALGORITHM; ANALYSIS; BLOOD; BLOOD GLUCOSE MONITORING; CHILD; CONSENSUS; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; GLUCOSE BLOOD LEVEL; HEALTH CARE SURVEY; HUMAN; REPRODUCIBILITY; RISK ASSESSMENT; STATISTICS AND NUMERICAL DATA;

ADULT; AGE FACTORS; ALGORITHMS; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; CHILD; CONSENSUS; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; HEALTH CARE SURVEYS; HUMANS; HYPOGLYCEMIC AGENTS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT;

EID: 84905905480     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/1932296814539589     Document Type: Article

References (20)

1. Krouwer JS, Cembrowski GS. A review of standards and statistics used to describe blood glucose monitor performance. J Diabetes Sci Technol. 2010;4(1):75-83.
2. Boren SA, Clarke WL. Analytical and clinical performance of blood glucose monitors. J Diabetes Sci Technol. 2010;4(1):84-97.
3. Klonoff DC. The need for clinical accuracy guidelines for blood glucose monitors. J Diabetes Sci Technol 2012;6(1):1-4.
4. US Food and Drug Administration. Guidance for industry and FDA staff: recommendations: clinical laboratory improvement amendments of 1988 (CLIA) waiver applications for manufacturers of in vitro diagnostic devices. Available at: http://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/ GuidanceDocuments/ucm079632.htm. Accessed December 1, 2013.
5. Krouwer J. Why manufacturers should embrace error grids. Available at: http://www.ivdtechnology.com/article/why-manufacturers-should-embrace-error- grids. Accessed October 29, 2013.
6. Clarke WL, Cox D, Gonder-Frederick LA, Carter W, Pohl SL. Evaluating clinical accuracy of systems for self-monitoring of blood glucose. Diabetes Care. 1987;10(5):622-628.
7. Parkes JL, Slatin SL, Pardo S, Ginsberg BH. A new consensus error grid to evaluate the clinical significance of inaccuracies in the measurement of blood glucose. Diabetes Care. 2000;23:1143-1148.
8. Diabetes Control and Complications Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977-986.
9. Rapid-acting insulin approved for marketing. Am J Health Syst Pharm. 1996;53(19):2250.
10. Johnson SR, Cooper MN, Jones TW, Davis EA. Long-term outcome of insulin pump therapy in children with type 1 diabetes assessed in a large population-based case-control study. Diabetologia. 2013;56:2392-2400.
11. Klonoff DC. The Food and Drug Administration is now preparing to establish tighter performance requirements for blood glucose monitors. J Diabetes Sci Technol. 2010;4:499-504.
12. Seaquist ER, Anderson J, Childs B, et al. Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society. Diabetes Care. 2013;36(5):1384-1395. doi:10.2337/dc12-2480.
13. Ostenson CG, Geelhoed-Duijvestijn P, Lahtela J, et al. Selfreported non-severe hypoglycaemic events in Europe. Diabetes Med. 2014;31(1):92-101.
14. Floyd B, Chandra P, Hall S, et al. Comparative analysis of the efficacy of continuous glucose monitoring and self-monitoring of blood glucose in type 1 diabetes mellitus. J Diabetes Sci Technol. 2012;6(5):1094-1102.
15. Vigersky RA, Fonda SJ, Chellappa M, Walker MS, Ehrhardt NM. Short-and long-term effects of real-time continuous glucose monitoring in patients with type 2 diabetes. Diabetes Care. 2012;35(1):32-38.
16. Freckmann G, Schmid C, Baumstark A, Pleus S, Link M, Haug C. System accuracy evaluation of 43 blood glucose monitoring systems for self-monitoring of blood glucose according to DIN EN ISO 15197. J Diabetes Sci Technol. 2012;6(5):1060-1075.
17. Klonoff DC, Reyes J. Do currently available blood glucose monitors meet regulatory standards? 1-day public meeting in Arlington, Virginia. J Diabetes Sci Technol. 2013;7(4): 1071-1083.
18. Weiss SL, Cembrowski GS, Mazze RS. Patient and physician analytic goals for self-monitoring blood glucose instruments. Am J Clin Pathol. 1994;102(5):611-615.
19. Cox DJ, Clarke WL, Gonder-Frederick L, et al. Accuracy of perceiving blood glucose in IDDM. Diabetes Care. 1985;8:529-536.
20. Pfützner A, Klonoff DC, Pardo S, Parkes JL. Technical aspects of the Parkes error grid. J Diabetes Sci Technol. 2013;7:1275-1281.